Dyadic International (NASDAQ:DYAI) Shares Cross Above Fifty Day Moving Average - Here's What Happened

Dyadic International, Inc. (NASDAQ:DYAI - Get Free Report) shares crossed above its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $1.40 and traded as high as $1.87. Dyadic International shares last traded at $1.74, with a volume of 88,001 shares changing hands.

Wall Street Analyst Weigh In

Separately, HC Wainwright reaffirmed a "buy" rating and issued a $6.00 target price on shares of Dyadic International in a research note on Thursday, November 14th.

Dyadic International Stock Performance

The stock has a fifty day moving average of $1.41 and a 200-day moving average of $1.40. The firm has a market capitalization of $51.48 million, a P/E ratio of -7.56 and a beta of 0.88. The company has a quick ratio of 5.15, a current ratio of 5.15 and a debt-to-equity ratio of 1.54.

Dyadic International (NASDAQ:DYAI - Get Free Report) last released its earnings results on Tuesday, November 12th. The biotechnology company reported ($0.01) earnings per share for the quarter, beating analysts' consensus estimates of ($0.07) by $0.06. The business had revenue of $1.96 million during the quarter, compared to the consensus estimate of $1.05 million. Dyadic International had a negative net margin of 188.09% and a negative return on equity of 149.16%. During the same quarter last year, the firm earned ($0.06) earnings per share. On average, research analysts anticipate that Dyadic International, Inc. will post -0.18 EPS for the current year.

Institutional Investors Weigh In On Dyadic International

A hedge fund recently raised its stake in Dyadic International stock. Chapin Davis Inc. raised its holdings in shares of Dyadic International, Inc. (NASDAQ:DYAI - Free Report) by 2.5% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 868,301 shares of the biotechnology company's stock after purchasing an additional 21,000 shares during the quarter. Chapin Davis Inc. owned approximately 2.97% of Dyadic International worth $903,000 at the end of the most recent reporting period. Institutional investors own 27.95% of the company's stock.

About Dyadic International

Dyadic International, Inc, a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States and internationally. It utilizes C1-cell protein production platform based on an industrially proven microorganism (C1) for the development and production of biologic products including enzymes and other proteins for human and animal health.